News Detail
New Delhi, 5 Jan 2024: The National Pharmaceutical Pricing Authority (NPPA) has revised the retail prices of antibiotic drug ceftazidime pentahydrate manufactured by drug majors Cipla and Wockhardt significantly downwards after it has come to know that it contains a compound that......
View Details
Source : Pharmabiz
National Pharmaceutical Pricing Authority
NPPA
antibiotic drug
ceftazidime pentahydrate
Cipla
Wockhardt
methodology
Pfizer
Zavicefta
Samarth Life Sciences
ceftazidime pentahydrate
avibactam
Pharmatrac
Wockhardt
DPCO
2013
Related News
- Cipla gets nod to market Afrezza insulin inhalation powder in India (12-12-2024)
- UK regulator probes anti-depressants safety alerts after suicide link (12-12-2024)
- Haryana Food Department to Crack Down on Fake Protein Supplements After Major Bust (12-12-2024)
- Drug inspector sentenced to 3-yr rigorous imprisonment (12-12-2024)
- 11.12 crore worth of short-shelf life medicines expired due to delayed supply to TNMSC: CAG Report (12-12-2024)
- Ayush Ministry amends D&C Act to add Homoeopathy, Sowa Rigpa books and Pharmacopoeias (12-12-2024)
- Construction of all three bulk drug parks are in progress: Ministry of chemicals (12-12-2024)
- Four-member gang nabbed for selling ‘Mephentermine Sulphate’ injections in Hyderabad (12-12-2024)
- Combining BCL-2 and BTK inhibitors shows promise in chronic lymphocytic leukemia (CLL) (11-12-2024)
- Punjab cop arrests man for narcotic drugs case, gets fined by court (11-12-2024)